All Stories

  1. Long-Term Prognostic Value of Automated Measurements in Nuclear Cardiology: Comparisons with Expert Scoring
  2. Investigating the genetic characteristics of CAD: Is there a role for myocardial perfusion imaging techniques?
  3. Automated Analysis vs. Expert Reading in Nuclear Cardiology: Correlations with the Angiographic Score
  4. Anosognosia in Dementia: Evaluation of Perfusion Correlates Using 99mTc-HMPAO SPECT and Automated Brodmann Areas Analysis
  5. Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations
  6. Correlation of Neuropsychiatric Symptoms in Dementia with Brain Perfusion: A 99mTc-SPECT-HMPAO Study with Brodmann Areas Analysis
  7. α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism
  8. From courage to ischaemia: is still there a role for myocardial perfusion imaging (MPI) in stable coronary artery disease?
  9. Eating Disorders in Frontotemporal Dementia and Alzheimer’s Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis
  10. Fahr’s syndrome due to hypoparathyroidism revisited: A case of parkinsonism and a review of all published cases
  11. COVID-19 crisis: will online learning have negative consequences to our students?
  12. COVID‐19 and nuclear cardiology: Introducing the “forward” virtual visit
  13. Differences of apathy perfusion correlates between Alzheimer’s disease and frontotemporal dementia. A 99mTc-HMPAO SPECT study with automated Brodmann areas analysis
  14. In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers?
  15. A second wave of COVID-19 infections should not lead to a new disruption of services in nuclear cardiology
  16. Premature CAD: Conventional Screening and Diagnostic Strategies May Not Capture the “Whole Picture”
  17. Exercise stress testing: Time to restart in nuclear cardiology?
  18. SLC2A3 rs12842 polymorphism and risk for Alzheimer’s disease
  19. Low-dose radiation cancer risk hypothesis may lead to ‘radiophobia’-driven imaging avoidance?
  20. Pet tracers for vulnerable plaque imaging
  21. Novel approaches for the management of coronary artery disease
  22. Impact of renin–angiotensin–aldosterone system polymorphisms on myocardial perfusion: Correlations with myocardial single photon emission computed tomography-derived parameters
  23. Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
  24. Detection of extramedullary hematopoietic tissue in a patient with beta-thalassemia major on Tc99m-sestamibi parathyroid scintigraphy
  25. Obstrucción de la vena cava superior por seminoma testicular con metástasis en el mediastino. Imagen de vías colaterales durante la gammagrafía por hemorragia intestinal con hematíes marcados con 99mTc
  26. SPECT and PET imaging in Alzheimer’s disease
  27. Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA
  28. 18F-fluorothymidine PET imaging in gliomas: an update
  29. SPECT and PET in ischemic heart failure
  30. Magnetic Resonance Spectroscopy and Single-Photon Emission Computed Tomography in the Evaluation of Cerebral Tumors: A Case Report
  31. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease
  32. Radioisotopic vs Non-Radioisotopic Methods for Myocardial Viability Identification
  33. Myocardial perfusion and left ventricular quantitative parameters obtained using gated myocardial SPECT: Comparison of three software packages
  34. Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer’s Disease
  35. Brain Perfusion SPECT with Brodmann Areas Analysis in Differentiating Frontotemporal Dementia Subtypes
  36. The Emerging Roles of Adiponectin in Female Reproductive System-Associated Disorders and Pregnancy
  37. Radiolabeling approaches of nanoparticles with99mTc
  38. Metabolism-Related Cytokine and Hormone Levels in the Serum of Patients with Myelodysplastic Syndromes
  39. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer’s disease from frontotemporal degeneration syndromes
  40. Ghrelin
  41. Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
  42. Incremental prognostic value of 99mTc-tetrofosmin early poststress pulmonary uptake. Determination of the optimal cut-off value
  43. SPECT and PET Imaging of Meningiomas
  44. Clinical Significance of Tetrofosm in Extracardiac Uptake During Myocardial Perfusion Imaging
  45. Does hybrid diagnostic imaging in cardiology have the same significance as in oncology?
  46. Sequence Variations in the FII , FV , F13A1 , FGB and PAI-1 Genes are Associated with Differences...
  47. Current and potential roles of ghrelin in clinical practice
  48. Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance?
  49. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome
  50. Alzheimers Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
  51. Alzheimer's Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
  52. Myocardial Perfusion SPECT Imaging in Patients after Percutaneous Coronary Intervention
  53. Darwinian molecular imaging in nuclear cardiology
  54. Long-term prognostic value of early poststress 99mTc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging
  55. Impact of ACE and ApoE polymorphisms on myocardial perfusion: correlation with myocardial single photon emission computed tomographic imaging
  56. On the accuracy of a mutual information algorithm for PET-MR image registration
  57. Evaluation of brain perfusion in specific Brodmann areas in Frontotemporal dementia and Alzheimer disease using automated 3-D voxel based analysis
  58. P065 Profile of metabolism-related cytokines in myelodysplastic syndromes
  59. Long-term prognostic value of heart-rate recovery after treadmill testing in patients with diabetes mellitus
  60. The Role of Nuclear Medicine in Vascular Dementia
  61. SPECT Imaging and Cerebrovascular Disease
  62. Myocardial Perfusion SPECT Imaging in Patients after Coronary Revascularization
  63. Incremental prognostic value of 99mTc-tetrofosmin myocardial SPECT after percutaneous coronary intervention
  64. Heart-rate recovery as a clinical marker of cardiovascular autonomic dysfunction in diabetic patients
  65. Drug enhancement of myocardial tracer uptake during myocardial perfusion imaging
  66. Long-Term Prognostic Value of Tc-99m Tetrofosmin Myocardial Gated-SPECT Imaging in Asymptomatic Patients After Percutaneous Coronary Intervention
  67. Radiopharmaceuticals in Neurological and Psychiatric Disorders
  68. Myocardial Perfusion SPECT Imaging in Patients after Coronary Revascularization
  69. SPECT Imaging and Cerebrovascular Disease
  70. 99mTechnetium-ciprofloxacin Scintigraphy for the Evaluation of Spinal Infections
  71. Multiple Meningiomas
  72. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography
  73. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer
  74. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer
  75. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI